Educational and occupational outcomes in Swedish children treated for sarcomas: A nationwide registry‐based study

Author:

Grundström Albin1,Harila Arja12,Lönnerblad Malin134ORCID

Affiliation:

1. Department of Women's and Children's Health Uppsala University Uppsala Sweden

2. Department of Pediatric Oncology Uppsala University Hospital Uppsala Sweden

3. Department of Special Education Stockholm University Stockholm Sweden

4. Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

Abstract

AbstractBackgroundMany children treated for cancer experience a negative impact on their academic performance; however, most studies of children treated for sarcomas have not investigated academic performance. Our aim was to explore how Swedish children treated for sarcomas perform academically, as well as how they adjust to life afterwards.ProcedureWe compared 167 pediatric sarcoma survivors with 776 matched, non‐sibling controls without a history of cancer, in a retrospective cohort study using data from nationwide registries. Primary outcomes were grades at the end of compulsory education, high school eligibility, post‐compulsory education (i.e., education after school Year 9), employment, and sickness or activity compensation.ResultsPediatric sarcoma survivors were more likely to be ineligible for high school (odds ratio [OR] 1.76; p = .045) and more likely to fail Swedish (OR 2.12; p = .046), mathematics (OR 2.27; p = .011), and/or physical education (OR 2.24; p = .004), compared with controls. Survivors were less likely to have been employed (OR 0.58; p = .027) and received sickness or activity compensation more often (OR 2.49; p = .008) compared with controls.ConclusionsPediatric sarcoma survivors have poorer academic performance compared to peers without cancer in multiple school subjects. Survivors seem to catch up during post‐compulsory education, but might struggle to find employment.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference41 articles.

1. HowladerN NooneA KrapchoM et al.SEER cancer statistics review 1975–2017.National Cancer Institute. Accessed May 2 2023.https://seer.cancer.gov/csr/1975_2017/index.html

2. Ewing sarcoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3